Susquehanna International Group, LLP Vivos Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.83 - $21.25 $34,434 - $881,598	41,487 New	41,487 $27,000
Q2 2022 Aug 15, 2022	SELL	$1.12 - $2.18 $26,588 - $51,753	-23,740 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.63 - $3.63 $69,403 - $154,561	-42,579 Reduced 64.2%	23,740 $64,000
Q4 2021 Feb 14, 2022	BUY	$2.25 - $4.11 $25,686 - $46,919	11,416 Added 20.79%	66,319 $150,000
Q3 2021 Nov 15, 2021	BUY	$2.71 - $5.9 $148,787 - $323,927	54,903 New	54,903 $222,000

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $60.3M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.